|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.530 EGP | 0.00% |
|
+4.79% | +34.21% |
| 17/05 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 20/02 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 872M 17.22M 15.13M 14.12M 12.96M 24.26M 1.65B 24.86M 167M 65.49M 816M 64.65M 63.24M 2.82B | P/E 2026 * |
25.5x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 793M 15.65M 13.75M 12.83M 11.78M 22.05M 1.5B 22.59M 152M 59.51M 742M 58.74M 57.47M 2.56B | EV / Sales 2026 * |
0.67x | EV / Sales 2027 * | 0.49x |
| Free-Float |
42% | Yield 2026 * |
1.96% | Yield 2027 * | 2.61% |
| 1 week | +4.79% | ||
| Current month | +27.50% | ||
| 1 month | +28.57% | ||
| 3 months | +28.57% | ||
| 6 months | +10.87% | ||
| Current year | +34.21% |
| 1 week | 1.45 |  | 1.6 |
| 1 month | 1.2 | | 1.6 |
| Current year | 1.02 | | 1.68 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 01/01/2002 |
Tamir Saeed
BRD | Director/Board Member | - | 01/01/2021 |
Norbert Lurz
BRD | Director/Board Member | - | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +4.79% | -27.49% | -43.33% | 17.22M | |
| -3.59% | -1.25% | +54.07% | +157.64% | 1,079B | |
| -3.54% | -1.24% | +53.09% | +52.84% | 640B | |
| -2.50% | -0.32% | +35.29% | +71.22% | 465B | |
| -2.41% | +0.43% | +35.21% | +29.71% | 353B | |
| -2.05% | -0.83% | +33.24% | +39.01% | 301B | |
| -2.63% | +0.24% | +10.61% | +13.70% | 271B | |
| -2.09% | +3.15% | +1.66% | -39.50% | 228B | |
| -1.89% | +2.31% | +26.12% | +62.32% | 209B | |
| -2.56% | -1.09% | +12.79% | +70.00% | 165B | |
| Average | -2.35% | +4.83% | +23.46% | +41.36% | 370.97B | |
| Weighted average by Cap. | -2.94% | +4.86% | +38.27% | +75.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 23.49M 20.64M 19.26M 17.68M 33.09M 2.25B 33.91M 228M 89.33M 1.11B 88.18M 86.27M 3.85B | 1.55B 30.63M 26.92M 25.12M 23.06M 43.16M 2.93B 44.23M 298M 117M 1.45B 115M 113M 5.02B |
| Net income | 206M 4.07M 3.57M 3.33M 3.06M 5.73M 389M 5.87M 39.54M 15.46M 193M 15.26M 14.93M 666M | 283M 5.59M 4.91M 4.58M 4.2M 7.87M 535M 8.06M 54.32M 21.24M 265M 20.97M 20.52M 915M |
| Net Debt | -79.7M -1.57M -1.38M -1.29M -1.18M -2.22M -151M -2.27M -15.3M -5.98M -74.56M -5.91M -5.78M -258M | -110M -2.17M -1.91M -1.78M -1.63M -3.06M -208M -3.13M -21.12M -8.26M -103M -8.15M -7.97M -356M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | EGP 1.530 | 0.00% | 189,715,387 |
| 28/07/26 | EGP 1.530 | +2.68% | 95,186,580 |
| 27/07/26 | EGP 1.490 | -1.97% | 106,115,400 |
| 26/07/26 | EGP 1.520 | +4.11% | 215,276,458 |
| 22/07/26 | EGP 1.460 | +4.29% | 243,929,401 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.530EGP
Average target price
1.570EGP
Spread / Average Target
+2.61%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
